Related Experiment Video

Updated: Jul 14, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

[Predementia syndromes and mild cognitive impairment: diagnosis and progression to dementia]

Francesco Panza, Alessia D'Introno, Anna Maria Colacicco

    Recenti Progressi in Medicina
    |June 22, 2007
    PubMed

    Insights

    Mild Cognitive Impairment (MCI) is a prodromal phase for Alzheimer's disease (AD), but conversion rates vary. MCI classification stability differs between population-based and clinic-based studies.

    Area of Science:

    • Gerontology
    • Neurology
    • Epidemiology

    Background:

    • Clinical predementia syndromes, including Mild Cognitive Impairment (MCI), lack consistent epidemiological investigation.
    • MCI is recognized as a potential prodromal phase for Alzheimer's disease (AD), prompting significant research interest.

    Discussion:

    • Conversion rates from MCI to AD and dementia exhibit considerable variability across studies.
    • This variability is attributed to differences in study populations and follow-up durations.
    • Recent findings indicate MCI classification instability in population-based studies, contrasting with more uniform progression in clinic-based settings.

    Key Insights:

    • MCI is a critical transitional phase in neurodegenerative disease progression.
    • Epidemiological data on MCI progression is essential for understanding Alzheimer's disease trajectories.
    • Study design (population-based vs. clinic-based) impacts the observed stability of MCI diagnosis.

    Outlook:

    • Further research is needed to standardize MCI diagnostic criteria and epidemiological assessment.
    • Investigating the factors influencing MCI classification stability is crucial for accurate prognostication.
    • Longitudinal studies with standardized methodologies will enhance understanding of MCI progression and AD prediction.

    More Related Videos

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    Related Concept Videos

    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    Dementia l: Introduction01:22

    Dementia l: Introduction

    Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
    Dementia01:30

    Dementia

    Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
    The progression of dementia is generally gradual.
    Alzheimer Disease ll: Pathophysiology01:23

    Alzheimer Disease ll: Pathophysiology

    Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
    Cognitive Development During Adulthood01:30

    Cognitive Development During Adulthood

    Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...